Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GMPharma Consult ApS
APS
Active
CVR 42760137
Lyngbakken 42, 3400
Hillerød
Engineering activities and related technical consultancy
· NACE 7112
Est. 2021
1 employees
Watchlist
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
GMPharma Consult ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
807
0
-35
Staff expenses
-589
-0
-0
EBITDA
132
-15
-35
Depreciation & amort.
-0
-0
-0
EBIT
132
-15
-35
Net financials
-3
-2
-2
Profit before tax
129
-16
-36
Tax
29
-3
3
Net profit
101
-13
-39
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
173
166
119
Equity
141
128
88
Long-term debt
29
0
0
Short-term debt
4
39
31
Total debt
33
39
31
Financial ratios
5-year trend
EBITDA margin
-3452000.0%
This company
15.8%
Market median
-21848201% vs market
2022
2024
Equity ratio
74.2%
This company
38.2%
Market median
+94% vs market
2022
2024
Return on equity
-44.7%
This company
18.4%
Market median
-343% vs market
2022
2024
Net profit margin
-3942900.0%
This company
8.1%
Market median
-48677878% vs market
2022
2024
Asset turnover
-0.29×
This company
1.12×
Market median
-126% vs market
2022
2024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-12-31
View
PDF
More on GMPharma Consult ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
